ETrade Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $1.24M | Sell |
20,764
-7,364
| -26% | -$438K | 0.02% | 321 |
|
|
2020
Q2 | $1.96M | Sell |
28,128
-982
| -3% | -$68.5K | 0.04% | 220 |
|
|
2020
Q1 | $1.32M | Buy |
29,110
+6,436
| +28% | +$292K | 0.03% | 239 |
|
|
2019
Q4 | $1.48M | Sell |
22,674
-4,341
| -16% | -$282K | 0.03% | 263 |
|
|
2019
Q3 | $1.68M | Buy |
27,015
+1,992
| +8% | +$124K | 0.04% | 235 |
|
|
2019
Q2 | $1.78M | Buy |
25,023
+960
| +4% | +$68.4K | 0.05% | 229 |
|
|
2019
Q1 | $1.89M | Buy |
24,063
+9,282
| +63% | +$728K | 0.05% | 212 |
|
|
2018
Q4 | $1.25M | Buy |
14,781
+1,717
| +13% | +$145K | 0.04% | 240 |
|
|
2018
Q3 | $2.24M | Sell |
13,064
-2,841
| -18% | -$486K | 0.06% | 179 |
|
|
2018
Q2 | $2.06M | Buy |
15,905
+3,078
| +24% | +$398K | 0.06% | 177 |
|
|
2018
Q1 | $1.32M | Sell |
12,827
-2,132
| -14% | -$220K | 0.04% | 255 |
|
|
2017
Q4 | $1.28M | Buy |
14,959
+250
| +2% | +$21.4K | 0.04% | 293 |
|
|
2017
Q3 | $1.25M | Buy |
14,709
+3,047
| +26% | +$259K | 0.04% | 267 |
|
|
2017
Q2 | $883K | Sell |
11,662
-644
| -5% | -$48.8K | 0.03% | 308 |
|
|
2017
Q1 | $813K | Sell |
12,306
-896
| -7% | -$59.2K | 0.03% | 322 |
|
|
2016
Q4 | $837K | Sell |
13,202
-484
| -4% | -$30.7K | 0.04% | 286 |
|
|
2016
Q3 | $871K | Sell |
13,686
-937
| -6% | -$59.6K | 0.04% | 260 |
|
|
2016
Q2 | $1.09M | Sell |
14,623
-1,178
| -7% | -$87.6K | 0.06% | 194 |
|
|
2016
Q1 | $1.06M | Sell |
15,801
-56
| -0.4% | -$3.74K | 0.06% | 189 |
|
|
2015
Q4 | $1.07M | Buy |
15,857
+308
| +2% | +$20.8K | 0.06% | 176 |
|
|
2015
Q3 | $831K | Buy |
15,549
+1,188
| +8% | +$63.5K | 0.05% | 199 |
|
|
2015
Q2 | $904K | Sell |
14,361
-1,031
| -7% | -$64.9K | 0.05% | 196 |
|
|
2015
Q1 | $740K | Buy |
15,392
+1,379
| +10% | +$66.3K | 0.04% | 218 |
|
|
2014
Q4 | $465K | Buy |
14,013
+2,423
| +21% | +$80.4K | 0.03% | 316 |
|
|
2014
Q3 | $340K | Buy |
11,590
+6,315
| +120% | +$185K | 0.02% | 345 |
|
|
2014
Q2 | $205K | Buy |
5,275
+2,989
| +131% | +$116K | 0.01% | 413 |
|
|
2014
Q1 | $96K | Buy |
+2,286
| New | +$96K | 0.01% | 492 |
|